Medicare Enrolled

Dr. Adam Nassery, MD

Interventional Pain Medicine Physician · Aventura, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
21097 NE 27TH COURT, Aventura, FL 33180
3059745533
In practice since 2014 (11 years)
NPI: 1275952863 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nassery from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nassery? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nassery

Dr. Adam Nassery is an interventional pain medicine physician in Aventura, FL, with 11 years in practice. Based on federal Medicare data, Dr. Nassery performed 7,625 Medicare services across 2,092 unique beneficiaries.

Between the years covered by Open Payments, Dr. Nassery received a total of $25,517 from 48 pharmaceutical and/or device companies across 545 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nassery is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice▲ Top 19% volume in FL$ $25,517 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,625
Medicare services
Top 19% in FL for interventional pain medicine physician
2,092
Unique beneficiaries
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~693 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Steroid injection (triamcinolone)3,023$1$9
Hospital follow-up visit, high complexity858$101$920
Dexamethasone injection (steroid)781$0$1
Hospital follow-up visit, moderate complexity517$67$643
Office visit, established patient (30-39 min)447$106$913
Office visit, established patient (20-29 min)275$75$644
Initial hospital admission, high complexity251$144$1,414
Fluoroscopic guidance for needle placement214$97$807
Joint injection, major joint177$54$513
Injection of substance into lower spine canal using imaging guidance164$210$1,874
Critical care, first 30-74 min136$186$2,008
Initial hospital admission, moderate complexity104$106$968
Drug screening test80$61$249
Injection of trigger points, 3 or more muscles67$36$451
New patient office visit (45-59 min)57$137$1,123
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms49$153$626
Injection of substance into middle or upper spine canal using imaging guidance40$215$1,906
Administration of psychological or neuropsychological test by technician, first 30 minutes38$28$238
Injection of lower or sacral spine facet joint using imaging guidance, single level37$203$1,577
New patient office visit, complex (60-74 min)36$186$1,587
Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance35$134$1,219
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose34$98$561
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level32$259$1,941
Evaluation of neuropsychological test, first hour27$107$908
Injection of upper or middle spine facet joint using imaging guidance, single level25$172$1,537
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face24$148$1,254
Office visit, established patient, complex (40-54 min)21$151$1,280
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms20$242$988
Injection of trigger points, 1-2 muscles19$32$398
Injection of lower or sacral spine facet joint using imaging guidance, second level19$110$811
Injection of upper or middle spine facet joint using imaging guidance, second level18$99$794
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$25,517
Total received (2018-2024)
Avg $3,645/year across 7 years
Top 10% in FL for interventional pain medicine physician
48
Companies
545
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,975 (78.3%)
Scientific / Research
Research funding and grants
$3,636 (14.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,906 (7.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,069
2023
$3,109
2022
$4,557
2021
$5,951
2020
$1,727
2019
$1,706
2018
$3,399

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$8,704
BIOTRONIK NRO, Inc.
$5,770
BOSTON SCIENTIFIC CORPORATION
$3,270
Spinal Simplicity, LLC
$2,039
Vertos Medical, Inc.
$722
Boston Scientific Corporation
$521
Scilex Pharmaceuticals Inc.
$479
Medtronic USA, Inc.
$438
SCILEX PHARMACEUTICALS INC.
$377
SPR Therapeutics, Inc
$331
RedHill Biopharma Inc.
$320
Medtronic, Inc.
$296
Forte Bio-Pharma LLC
$208
Flowonix Medical Incorporated
$143
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$142
Nevro Corp.
$134
PFIZER INC.
$131
Collegium Pharmaceutical, Inc.
$120
FORTE BIO-PHARMA LLC
$116
Amniox Medical, Inc.
$115
Stimwave Technologies Incorporated
$113
Relievant Medsystems, Inc.
$106
BioDelivery Sciences International, Inc.
$99
Biohaven Pharmaceutical Holding Company Ltd.
$56
Teva Pharmaceuticals USA, Inc.
$56
Sentynl Therapeutics, Inc.
$54
Almatica Pharma LLC
$53
Valinor Pharma, LLC
$52
Merz Pharmaceuticals, LLC
$51
US WorldMeds, LLC
$48
Kowa Pharmaceuticals America, Inc.
$43
Averitas Pharma Inc.
$40
SI-BONE, INC.
$40
DePuy Synthes Sales Inc.
$35
Avanos Medical
$29
VERTEX PHARMACEUTICALS INCORPORATED
$27
Alnylam Pharmaceuticals Inc.
$25
Azurity Pharmaceuticals, Inc.
$25
Masimo Corporation
$24
ARGENX US, INC.
$23
Virtus Pharmaceuticals LLC
$22
SI-BONE, Inc.
$21
Curonix LLC
$21
Medline Industries, Inc.
$19
Nalu Medical, Inc.
$16
IBSA Pharma Inc.
$14
Hikma Pharmaceuticals USA
$14
GRT US Holding, Inc.
$13
Top 3 companies account for 69.5% of total payments
Associated products mentioned in payments ›
AUSTEDO · Austedo XR · BELBUCA · BIOTRONIK · BUNAVAIL 2.1 mg 30-count box · COMIRNATY · COOLIEF* COOLED RADIOFREQUENCY · Custom Anesthesia Procedure Packs · ETERNA · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GIVLAARI · GRALISE · HA MINUTEMAN G3-R · HORIZANT · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · KYPHON Balloon Kyphoplasty · KYPHON EXPRESS II KYPHOPAK TRAY · Kloxxado · LEVORPHANOL TARTRATE · LICART · Levorphanol Tartrate · Livalo · MONOVISC · MOVANTIK · MYOBLOC · Movantik · NALOCET · NEOX · NURTEC ODT · Nalocet · Nalu Neurostimulation System · PACEL · PAXLOVID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · PRODIGY · PROLATE · Patient SafetyNet System · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · Prometra II · Prospera · QUTENZA · Qutenza · RELISTOR · SEGLENTIS · SPECTRA WAVEWRITER · SPRINT PNS System · SYNCHROMED · Senza Spinal Cord Stimulation System · StimQ Peripheral Nerve StimulatorSystem · VYVGART HYTRULO · WAVEWRITER ALPHA · XTAMPZA · Xeomin · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (78%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for interventional pain medicine physician in FL.

Equivalent to $335 per 100 Medicare services performed
Looking for a interventional pain medicine physician in Aventura?
Compare interventional pain medicine physicians in the Aventura area by procedure volume, costs, and industry payment transparency.
Browse interventional pain medicine physicians nearby

Geographic Context

Interventional Pain Medicine Physicians within 10 mi
34
Per 100K population
1.3
County median income
$68,694
Nearest hospital
HCA FLORIDA AVENTURA HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Nassery is a mixed practice specialist, with above-average Medicare volume (top 19% in FL), and high industry engagement (low-engagement, top 10%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Nassery experienced with steroid injection (triamcinolone)?
Based on Medicare claims data, Dr. Nassery performed 3,023 steroid injection (triamcinolone) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nassery receive payments from pharmaceutical companies?
Yes. Dr. Nassery received a total of $25,517 from 48 companies across 545 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nassery's costs compare to other interventional pain medicine physicians in Aventura?
Dr. Nassery's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nassery) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →